Company profile
BIOXYTRAN, INC CIK 1445815
Ticker
BIXT (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Needham, MA 02494
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$2.12M
Total assets
$658.6K
Total liabilities
$3.25M
Stockholders' equity
-$2.59M
Cash & equivalents
—
Operating income
-$1.84M
Operating cash flow
-$526.5K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
493.5%
Equity / assets
-393.5%
CapEx / revenue
—
Operating cash flow / net income
0.25×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$2.12M
$658.6K
$3.25M
-$2.59M
2024
—
-$2.37M
$138.7K
$1.93M
-$1.79M
2023
—
-$4.47M
$139.4K
$3.24M
-$3.10M
2022
—
-$2.47M
$370.9K
$3.67M
-$3.30M
2021
—
-$4.03M
$119.3K
$3.28M
-$3.16M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Needham, MA 02494
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.